Drawing for IMACLA

USPTO serial 86401856

IMACLA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
LEE, YATSYE ISADORA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMACLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce W. Longbottom

Bruce W. Longbottom Eli Lilly and CompanyLilly Corporate CenterIndianapolis, IN 46285UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 6, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 6, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 9, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2017EX4GSOU EXTENSION 4 GRANTED
Feb 6, 2017EXT4SOU EXTENSION 4 FILED
Feb 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 13, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2016EX3GSOU EXTENSION 3 GRANTED
Jun 30, 2016EXT3SOU EXTENSION 3 FILED
Jun 30, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 30, 2016EX2GSOU EXTENSION 2 GRANTED
Jan 26, 2016EXT2SOU EXTENSION 2 FILED
Jan 26, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 11, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2015EX1GSOU EXTENSION 1 GRANTED
Sep 2, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 24, 2015EXT1SOU EXTENSION 1 FILED
Aug 24, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 31, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 14, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2014DOCKASSIGNED TO EXAMINER
Sep 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2014NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance